Novartis AG (XSWX:NOVNEE) GF Score: 80/100 (As of Jul. 09, 2026) — 11% Above Median


XSWX:NOVNEE Novartis AG XSWX:NOVNEE
80 GF Score
Price CHF119.30
GF Value CHF98.21
! 7 Warning Signs
View Full Analysis

What is Novartis AG GF Score?

Novartis AG XSWX:NOVNEE -0.52% 80 GF Score is 80 as of Jul. 09, 2026, which is 11% above its 10-year median of 72.00. GuruFocus rates XSWX:NOVNEE with a GF Score™ of 80/100 and a GF Value™ of CHF98.21. The stock has 7 warning signs investors should review.

Novartis AG has the GF Score of 80, which implies that the company is Likely to have average performance.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 4/10
2. Profitability Rank : 7/10
3. Growth Rank : 7/10
4. GF Value Rank : 6/10
5. Momentum Rank : 10/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Novartis AG is Likely to have average performance.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Novartis AG  (XSWX:NOVNEE) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Novartis AG GF Score Related Terms

XSWX:NOVNEE vs LLY, JNJ, ABBV: GF Score Comparison

For the Drug Manufacturers - General subindustry, Novartis AG's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novartis AG GF Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's GF Score distribution charts can be found below:

* The bar in red indicates where Novartis AG's GF Score falls into.


XSWX:NOVNEE
80GF Score
Novartis AG XSWX:NOVNEE
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 80 mean?
Novartis AG (XSWX:NOVNEE) has a GF Score of 80 as of Jul. 09, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Novartis AG and its competitors. This is 11% above median its historical median of 72.00. Over the past decade, Novartis AG's GF Score has ranged from 23.00 to 88.00.
Is Novartis AG's GF Score too high?
Novartis AG's current GF Score of 80 is 11% above median its 10-year median of 72.00. Over the past 10 years, this metric has ranged from a low of 23.00 to a high of 88.00. Overall, Novartis AG has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Novartis AG's GF Score compare to LLY and JNJ?
Novartis AG's GF Score of 80 can be compared against companies in the Drug Manufacturers industry. Historically, Novartis AG's own GF Score has ranged from 23.00 to 88.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Novartis AG and its competitors. Novartis AG's current GF Score is 80, which is 11% above median its own 10-year median of 72.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novartis AG stock overvalued right now?
Novartis AG (XSWX:NOVNEE) has a current GF Score of 80. The stock's GF Value™ is CHF98.21, compared to a current price of CHF119.30 — trading 21.5% above its estimated fair value. The current GF Score is 80, which is 11% above median its 10-year median of 72.00. Novartis AG's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Novartis AG (XSWX:NOVNEE), the current GF Score is 80 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novartis AG (XSWX:NOVNEE) Overvalued in 2026?

Based on GuruFocus' analysis, Novartis AG stock appears to be overvalued. The current stock price of CHF119.30 is trading 21.5% above its estimated GF Value™ of CHF98.21.

Key valuation signals for XSWX:NOVNEE:

  • GF Score: 80 (11% above median its 10-year median of 72.00)
  • GF Value™: CHF98.21 vs. price of CHF119.30 (21.5% above fair value)
  • GF Score™: 80/100 with 7 warning signs

No single metric tells the full story. See the XSWX:NOVNEE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novartis AG Business Description

Address Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
80GF Score

Get the complete analysis for XSWX:NOVNEE

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF119.30
Price
CHF98.21
GF Value